The largest database of trusted experimental protocols
Sourced in United States, China, United Kingdom, Germany, Japan, Canada, Australia, Spain, Italy

HepG2 is a well-characterized human liver cancer cell line derived from a hepatocellular carcinoma. It is commonly used as a model system for in vitro studies related to liver cell biology and function.

Automatically generated - may contain errors

438 protocols using hepg2

1

Engineered Cell Lines for Liver Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human immortalized liver LO2, HepG2, HepG2.2.15 and NIHT3T cell lines were purchased from Nanjing KeyGEN Biotech Co., Ltd (Nanjing, China). The co-transfection with the plasmids of pCMV-X and pcDNA3-sur
[12 (link)] was performed in LO2 cells using Lipofectamine 2000 (Invitrogen, USA) as described
[12 (link)]. After 48 hours, the transfected cells were incubated in selection medium containing 500 μg/ml or 800 μg/ml G418 (Genview, USA). The transfection efficiencies were tested by PCR (one primer is from survivin and another is from the vector), western blotting, as indicated. Then, the engineered cell line was termed LO2-X-S. All the engineered cell lines were cultured in RPMI Medium 1640 (GIBCO, USA) containing 100 U/ml penicillin, 100 μg/ml streptomycin and 10% fetal calf serum (FCS). HepG2 cells, HepG2-X cells
[42 (link)] and HepG2.2.15 cells were cultured in Dulbecco’s Modified Eagle’s medium (DMEM, GIBCO) containing 100 U/ml penicillin, 100 μg/ml streptomycin and 10% FCS.
+ Open protocol
+ Expand
2

Assessing HepG2 Biocompatibility in dLM-G-PEG Bioink

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human hepatocellular carcinoma cell line HepG2 (Sigma Aldrich Sweden AB) was used to check the biocompatibility of the dLM-G-PEG bioink during the gelation and printing process. HepG2 cells were cultured according to the manufacturer’s protocol, with Eagle’s minimal essential medium (MEM, 11095080), 10% fetal bovine serum (FBS, A3160502), and penicillin-streptomycin (10,000 U mL−1, 15140122). Cells were maintained in culture and passaged every 2–3 days at about 80–90% confluency. Once at proper confluency, cells were used for encapsulation. Briefly, HepG2 cells were dissociated from the culture plate with trypsin-EDTA (0.25% solution, Sigma-Aldrich AB) and centrifuged at 300× g for 4–5 min. The collected HepG2 cells were resuspended in 10% FBS. To sustain the same osmotic pressure in dLM-G-PEG, 10× concentrated MEM (21430020, Gibco) was added (1/10th volume) and the collected HepG2 cells in 10% FBS, were mixed thoroughly with the acellular bioink. HepG2 cells were used in the dLM-G-PEG at a concentration of 4 to 5 × 106 cells per ml. The prepared bioink with HepG2 cells was crosslinked for 1 h at 37 °C and loaded into a sterilized syringe for bioprinting while maintaining the temperature. Cell culture reagents for HepG2 cell culture and maintenance were obtained from Thermofisher Scientific.
+ Open protocol
+ Expand
3

Hepatocellular Carcinoma Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HCC cell lines HepG2 and Hep3B were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Bel-7402 cells were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Xuhui, Shanghai, China). HepG2/ADM cells were kindly provided by Prof. Kwok-Pui Fung (The Chinese University of Hong Kong, Hong Kong, China). The HepG2, Hep3B, HepG2/ADM and Bel-7402 cells were maintained in RPMI 1640 medium (Thermo Fisher Scientific, Waltham, MA, USA) containing 10% (v/v) foetal bovine serum (Thermo Fisher Scientific, Waltham, MA, USA) and 1% (v/v) penicillin-streptomycin (PS; 10,000 U/ml, Thermo Fisher Scientific, Waltham, MA, USA) at 37 °C in a 5% CO2 atmosphere.
+ Open protocol
+ Expand
4

Silencing CSTF2 in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human hepatocyte cell line LO2 and hepatocellular carcinoma cell line HepG2 were kindly provided by Procell Life Science & Technology Co., Ltd. (Wuhan, China). LO2 cells were cultured in RPMI-1640 (Gibco, USA) containing 10% fetal bovine serum (Gibco, USA). HepG2 cells were cultured in DMEM (Gibco, USA) supplemented with 10% fetal bovine serum (Gibco, USA). CSTF2 siRNAs were designed by Gene Pharma (Shanghai, China). The sequences of the siRNAs are listed in Supplementary Table 1. HepG2 cells were cultured in 6-well plates until they reached 50–70% confluence. Then HepG2 cells were transfected with siRNA using LipofectamineTM 3000 (Thermo Fisher Scientific, USA) according to the manufacturer’s manual. The cells were maintained in a humidified 5% carbon dioxide incubator at 37°C.
+ Open protocol
+ Expand
5

Evaluating PI3K Inhibitor Effects in HCC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HCC cells (HepG2 and HepG2/ADM and Bel-7402 cells Bel-7402/5-FU) were incubated in RPMI-1640 medium (Thermo Fisher Scientific, Waltham, MA, USA) and DMEM (Thermo Fisher Scientific), supplemented with 10% (v/v) fetal bovine serum (FBS; Thermo Fisher Scientific) and 1% (v/v) penicillin–streptomycin (Thermo Fisher Scientific) at 37°C in a humidified atmosphere of 5% CO2. KLT injection was purchased from Zhejiang Kanglaite Pharmaceutical Co., Ltd, (Zhejiang, China). PI3K activator (740 Y-P) was purchased from APEXBIO (Houston, TX, USA). It is a peptide with the sequence RQIKIWFQNRRMKWKKSDGGYM-DMS and a molecular weight of 3,270.72 Da. LY294002 was obtained from Sigma (St Louis, MO, USA). HepG2 and HepG2/ADM cell lines were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and Nanjing Keygen Biotech. Co. (Nanjing, China) respectively. Bel-7402 cells and Bel-7402/5-FU cell lines were kindly provided by Dr Zhang of LUYE PHARMA Group Ltd (Yantai, China). All procedures involving laboratory cells were approved by the institutional review board of Binzhou Medical University.
+ Open protocol
+ Expand
6

Knockdown and Overexpression of OLFM4 in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human liver carcinoma cells (HepG2) were purchased from ATCC (ATCC HB-8065). HepG2 cells were maintained in Dulbecco's modified Eagle medium (DMEM, catalog number: 11965118) containing 10% fetal bovine serum (Gibco, catalog number: 10099141C), 100 units/ml penicillin, and 0.1% (w/v) streptomycin (catalog number: 15140163) at 37°C in a humidified atmosphere of 5% CO2.
SiRNAs against OLFM4 and HIF-1α against OLFM4 were synthesized by Thermo Fisher Scientific. Table 2 lists the sequences of siRNAs. The full-length coding sequence of OLFM4 was cloned into pcDNA3.1 vector (Yuanjing Biotechnology, Guangzhou, Guangdong, China). For transfection, siRNAs or plasmids were transfected in HepG2 cells using Lipofectamine 3000 (Thermo Fisher Scientific, catalog number: L3000001) according to the manufacturer's instructions.
+ Open protocol
+ Expand
7

Hepatocellular Carcinoma Cell Lines: Knockdown of ALG3

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human liver cell line LO2 and hepatocellular cell lines SNU398, SNU449, MHCC97H, Hep3B, PLC/PRF/5, and HepG2 were purchased from the ATCC (Manassas, VA, United States). PLC/PRF/5, Hep3B, MHCC97H, and HepG2 cell lines were cultured in complete Dulbecco’s modified Eagle’s medium (Gibco, United States), and SNU398 and SNU449 cells were cultured in RPMI1640 medium (Gibco, United States); all cells were supplemented with 10% fetal bovine serum (FBS) at 37°C in a humidified incubator with 5% CO2 in the air.
HCC cell lines (Hep3B, HepG2, and SNU398) were transfected with siRNAs targeting ALG3 or control siRNA (HIPPOBIO, China) using Lipofectamine 2000 Reagent (Invitrogen, United States). The efficiency of the knockdown was confirmed using qRT-PCR analysis. The siRNA used were as follows: si-NC: 5′-UUC​UUC​GAA​GGU​GUC​ACG​UTT-3′, ALG3 siRNA#1: 5′-GGU​UUC​GUG​UAC​AUC​UUU​AUG-3′, and ALG3 siRNA#2: 5′-GGA​CCU​GAG​UCU​ACC​CUC​AGG-3’.
+ Open protocol
+ Expand
8

Modulating Glucose Metabolism in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human liver carcinoma cell line, HepG2, was obtained from American Type Culture Collection (ATCC, USA). HepG2 cells were grown in Dulbecco modified Eagle’s medium (Gibico, USA) supplemented with 1 × MEM nonessential amino acids (Invitrogen, USA). Media were supplemented with 10 U/mL penicillin, 10 μg/mL streptomycin, and 10% fetal calf serum. Cells between passage 1 and passage 20 were incubated at 37 °C and 5% CO2.
CDCA (50 μM) and GW4064 (5 μM) were used as natural and synthetic FXR agonists. GS (10 μM) was used as natural FXR antagonists. For isotopic tracer assay, HepG2 cells were incubated in 1:1 [1,6 − 13C2]-glucose and unlabeled glucose at a final total glucose concentration of 25 mM in glucose-free Dulbecco’s Modified Eagle’s Medium (DMEM).
HepG2 cells were transfected with control siRNA or siRNA targeting FXR or PDK4 respectively using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer’s instruction. Cells were cultured for 48 h before treatment with 5 μM of GW4064 or vehicle for another 24 h. qRT-PCR analysis was conducted to examine the expression of genes in glycolysis pathway.
+ Open protocol
+ Expand
9

Modulating circFASN and miR-33a in Liver Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hep-G2 and Huh7 (human hepatocellular adenocarcinoma) cell lines were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Hep-G2 and Huh7 cells were maintained in DMEM (Gibco, USA) supplemented with 10% FBS at 37 °C in a humidified atmosphere of 95% air with 5% CO2.
For circFASN overexpression and silencing, the circFASN plasmid and siRNA targeting the junction region of circFASN were purchased from Guangzhou Geneseed Biotech Co (Guangzhou, China). Hep-G2 and Huh7 cells were transfected with the overexpression plasmid or siRNA by using Lipo3000 Transfection Reagent (Invitrogen, USA).
For miR-33a overexpression and inhibition, Hep-G2 and Huh7 cells were transfected with 50 nM miRNA mimics (miR-33a) or 100 nM miRNA inhibitor (anti-miR-33a) (GenePharma, Shanghai, China) by using Lipo3000 Transfection Reagent (Invitrogen). Control groups were treated with equal concentrations of nontargeting mimic or inhibitor negative control sequences to control for nonspecific effects.
+ Open protocol
+ Expand
10

Hepatocyte Cell Lines Establishment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepa 1–6 (murine hepatoma cell lines), Hep3B and HepG2 (human hepatoma cell lines), SKLU-1 (telomerase negative human lung carcinoma cell lines), and HEK293 (adenoviral E1-transformed human embryonic kidney cell lines) were purchased from the American Type Culture Collection (Manassas, VA). Huh7 (human hepatoma cell lines) was obtained from the Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). Hep3B and HepG2 were cultured in EMEM (Invitrogen, Carlsbad, CA) with 10% FBS. Hepa1–6, SKLU-1, Huh7, and HEK293 cells were maintained in DMEM (Invitrogen) with 10% FBS.
For the establishment of cell lines stably expressing miR-122a dependent on the presence of tetracycline, HepG2 cells expressing Tet repressor vector, pcDNA 6/TR (Invitrogen), were isolated with blasticidin for 2 weeks. The selected cells were transfected with vector encoding pri-miR-122a which was cloned into the tetracycline response element vector, pcDNA 4/myc-His B (Invitrogen), and zeocin resistant colonies were isolated for 2 weeks.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!